The immune mechanism of the nasal epithelium in COVID-19–related olfactory dysfunction

S Chen, S Wang - Frontiers in Immunology, 2023 - frontiersin.org
During the first waves of the coronavirus disease 2019 (COVID-19) pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, olfactory …

Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers

A Perez-Favila, I Garza-Veloz… - International Journal of …, 2024 - mdpi.com
The COVID-19 pandemic has had a significant impact on the health and economy of the
global population. Even after recovery from the disease, post-COVID-19 symptoms, such as …

[HTML][HTML] Evaluating Molecular Mechanism of Viral Inhibition of Aerosolized Smart Nano-Enabled Antiviral Therapeutic (SNAT) on SARS-CoV-2-Infected Hamsters

AN Bauer, JF Williams, LR Pokhrel, S Garcia… - Toxics, 2024 - mdpi.com
Smart Nano-enabled Antiviral Therapeutic (SNAT) is a promising nanodrug that previously
demonstrated efficacy in preclinical studies to alleviate SARS-CoV-2 pathology in hamsters …

Heparanase‐1 and MMPs in Covid‐19 and non‐Covid‐19 pneumonia

V Masola, G Marrone, C Condoluci… - Proteoglycan …, 2024 - Wiley Online Library
Together with the ACE2 protein, heparan sulfate present at the level of the glycocalyx in the
lung epithelia is considered a cellular “co‐receptor” for the viral spike protein that allows …

Gene Expression Analysis of ACE2, TMPRSS2, and LZTFL1 in COVID-19 Patients: a pilot study

FM Saad, A Daif, M Sakr, H Ismail - Research Journal of Applied …, 2024 - journals.ekb.eg
The objective of this research was to assess gene expression levels of ACE2, TMPRSS2,
and LZTFL1 in COVID-19 patients from Egypt and investigate their potential association with …